ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
Here are the top 10 ASX 200 shares today
Share Gainers
Why ANZ, Lake Resources, ResMed, and Santos shares storming higher today
Healthcare Shares
Is the worst over for ResMed shares?
Share Market News
Here are the top 10 ASX 200 shares today
Share Gainers
Why Deep Yellow, Meteoric Resources, Novonix, and ResMed shares are storming higher
Share Market News
Here are the top 10 ASX 200 shares today
Healthcare Shares
Broker sees 'strong asymmetric upside risk' for ResMed shares
Cheap Shares
'Buying opportunity': 2 ASX 200 shares to jump on while they're cheap now
Blue Chip Shares
3 struggling ASX blue-chip shares going super cheap right now
Broker Notes
Morgans names more of the best ASX 200 shares to buy in September
Opinions
Here's why I added Resmed shares to my portfolio last week
ETFs
'Beyond our expectations': How to invest in obesity drugs like Ozempic with ASX ETFs
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
